CHLOROQUINE PHOSPHATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for chloroquine phosphate and what is the scope of freedom to operate?
Chloroquine phosphate
is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Hikma Pharms, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Suven Pharms, Teva, and Watson Labs, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for chloroquine phosphate. Seven suppliers are listed for this compound.
Summary for CHLOROQUINE PHOSPHATE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 10 |
NDAs: | 15 |
Drug Master File Entries: | 2 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 109 |
Clinical Trials: | 49 |
Patent Applications: | 1,986 |
What excipients (inactive ingredients) are in CHLOROQUINE PHOSPHATE? | CHLOROQUINE PHOSPHATE excipients list |
DailyMed Link: | CHLOROQUINE PHOSPHATE at DailyMed |
Recent Clinical Trials for CHLOROQUINE PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Arizona | Phase 1 |
Translational Genomics Research Institute | Phase 1 |
HonorHealth Research Institute | Phase 1 |
Pharmacology for CHLOROQUINE PHOSPHATE
Drug Class | Antimalarial |
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROQUINE PHOSPHATE
US Patents and Regulatory Information for CHLOROQUINE PHOSPHATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 087979-001 | Dec 21, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE | chloroquine phosphate; primaquine phosphate | TABLET;ORAL | 014860-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Natco Pharma Ltd | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 091621-001 | Jan 21, 2011 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Purepac Pharm | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 080886-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 087504-001 | Jan 13, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.